Altamira Therapeutics Ltd. Adjustments For Reconcile Profit Loss
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Reconcile Profit Loss of -$3.64 million for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-24.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForReconcileProfitLoss · last filed 2024-09-24
CHF
| Period end | Adjustments For Reconcile Profit Loss 6 month | Adjustments For Reconcile Profit Loss 12 month | Adjustments For Reconcile Profit Loss 12 month as first filed |
|---|---|---|---|
| 2023-12-31 | -7.27M CHF 20-F/A · filed 2024-04-22 | ||
| 2023-06-30 | -4.39M CHF 6-K · filed 2023-09-12 | ||
| 2022-12-31 | -12.24M CHF 20-F/A · filed 2024-04-22 | ||
| 2022-06-30 | -7.17M CHF 6-K · filed 2023-09-12 | ||
| 2021-12-31 | -13.85M CHF 20-F/A · filed 2024-04-22 | -14.18M CHF 20-F · filed 2022-04-12 | |
| 2021-06-30 | -5.39M CHF 6-K/A · filed 2023-08-21 | ||
| 2020-12-31 | -5.14M CHF 20-F · filed 2023-05-16 | ||
| 2020-06-30 | -2.22M CHF 6-K · filed 2021-09-08 | ||
| 2019-12-31 | -7.17M CHF 20-F · filed 2022-04-12 | ||
| 2019-06-30 | -4.06M CHF 6-K/A · filed 2020-09-17 | ||
| 2018-12-31 | -10.76M CHF 20-F · filed 2021-03-31 | ||
| 2018-06-30 | -7.28M CHF 6-K · filed 2019-08-15 | ||
| 2017-12-31 | -23.81M CHF 20-F · filed 2020-04-16 | ||
| 2016-12-31 | -29.73M CHF 20-F · filed 2019-03-14 | ||
| 2015-12-31 | -30.39M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Adjustments For Reconcile Profit Loss 6 month |
|---|---|
| 2024-06-30 | -$3.64M 6-K · filed 2024-09-24 |
| 2023-06-30 | -$4.79M 6-K · filed 2024-09-24 |